Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34 + ‐selected allogeneic transplantation
ADVANCES IN CELL AND GENE THERAPY · 2021
DOI: 10.1002/acg2.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift ADVANCES IN CELL AND GENE THERAPY, 2021. Verfasst von Christina Cho und 18 weiteren Autor:innen. Beteiligte Einrichtung: Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Medicine, Weill Cornell Medical College, New York, NY.
- Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
- Bone Marrow Transplant Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
- The Rockefeller University, New York, NY.
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Cho, C., Hilden, P., Avecilla, S. T., Barker, J. N., Castro-Malaspina, H., Giralt, S. A., Gyurkocza, B., Jakubowski, A. A., Maloy, M. A., O'Reilly, R. J., Papadopoulos, E. B., Peled, J. U., Ponce, D. M., Shaffer, B., Tamari, R., van den Brink, M. R. M., Young, J. W., Barba, P., & Perales, M. A. (2021). Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34 + ‐selected allogeneic transplantation. ADVANCES IN CELL AND GENE THERAPY. https://doi.org/10.1002/acg2.103
Vancouver
Cho C, Hilden P, Avecilla ST, Barker JN, Castro-Malaspina H, Giralt SA, et al. Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34 + ‐selected allogeneic transplantation. ADVANCES IN CELL AND GENE THERAPY. 2021. doi:10.1002/acg2.103
BibTeX
@article{Cho2021,
author = {Cho, Christina and Hilden, Patrick and Avecilla, Scott T and Barker, Juliet N and Castro-Malaspina, Hugo and Giralt, Sergio A and Gyurkocza, Boglarka and Jakubowski, Ann A and Maloy, Molly A and O'Reilly, Richard J and Papadopoulos, Esperanza B and Peled, Jonathan U and Ponce, Doris M and Shaffer, Brian and Tamari, Roni and van den Brink, Marcel R M and Young, James W and Barba, Pere and Perales, Miguel-Angel},
title = {Combining the disease risk index and hematopoietic cell transplant co‐morbidity index provides a comprehensive prognostic model for CD34 + ‐selected allogeneic transplantation},
journal = {ADVANCES IN CELL AND GENE THERAPY},
year = {2021},
doi = {10.1002/acg2.103}
}
EUVIMED